Accepted answer
2.5 mL of solution, and the rest depends on your dose. A 5 mg vial reconstituted to 2 mg/mL occupies 5 ÷ 2 = 2.5 mL. At a 1 mg weekly dose that is 5 weeks; at 2.4 mg weekly it is 2 weeks — and both of those assume the vial contains its label claim, which is the assumption a content assay exists to test. Subtract one draw's dead space per dose: a few microlitres on a fixed-needle syringe, up to a hundred on a luer one.
The part that matters: this is arithmetic, so let us do the arithmetic rather than argue about it.
Dead space quantified: a fixed-needle insulin syringe holds roughly 3 to 5 µL in the hub and needle after the plunger bottoms out. A luer-lock syringe with a detachable needle holds 35 to 100 µL depending on the hub design. At 5 mg/mL that is 15 to 25 µg lost per draw on the insulin syringe and 175 to 500 µg on the luer-lock — which over ten draws is the difference between losing a rounding error and losing half a milligram.
Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and condensation on a cold barrel makes it harder to read the meniscus.
Published data on syringe dead space quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more for conventional detachable-needle syringes.
One qualification: if your arithmetic and someone else's disagree by a factor of ten, one of you has made a unit error, and writing out the units at every step is the diagnostic.
If in doubt, use more diluent and accept the shorter usable window.
5Does this change at lower concentrations, or does adsorption start to dominate? – kwn_analytical 6 months ago 6Thank you — the worked example is what makes this usable. – v_ramaswamy 8 months ago add a comment